Tegaserod

Results: 11



#Item
1GASTROENTEROLOGY 2006;130:1421–1434  Pharmacological and Pharmacokinetic Aspects of Functional Gastrointestinal Disorders MICHAEL CAMILLERI,* LIONEL BUENO,# FABRIZIO de PONTI,§ JEAN FIORAMONTI,‡ R. BRUCE LYDIARD,储

GASTROENTEROLOGY 2006;130:1421–1434 Pharmacological and Pharmacokinetic Aspects of Functional Gastrointestinal Disorders MICHAEL CAMILLERI,* LIONEL BUENO,# FABRIZIO de PONTI,§ JEAN FIORAMONTI,‡ R. BRUCE LYDIARD,储

Add to Reading List

Source URL: www.romecriteria.org

Language: English - Date: 2006-05-12 14:34:56
2Angiotensin II receptor antagonists / Novartis / Valsartan / Tegaserod / Pharmaceutical industry / False Claims Act / Amlodipine/valsartan / Oxcarbazepine / Qui tam / Chemistry / Organic chemistry / Pharmacology

DOC Document

Add to Reading List

Source URL: www.namfcu.net

Language: English - Date: 2012-02-28 15:37:19
3DEPARTMENT  OF HEAL & HUMAN

DEPARTMENT OF HEAL & HUMAN

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-11-05 15:37:45
4Microsoft Word - Prior Authorization Request Form for Zelnorm.doc

Microsoft Word - Prior Authorization Request Form for Zelnorm.doc

Add to Reading List

Source URL: mainecarepdl.org

Language: English - Date: 2012-04-02 14:37:36
5Microsoft Word - AMS Newsletter  October[removed]24a.2007.doc

Microsoft Word - AMS Newsletter October[removed]24a.2007.doc

Add to Reading List

Source URL: www.motilitysociety.org

Language: English - Date: 2007-10-01 15:25:11
6Microsoft Word - Prior Authorization Request Form for Zelnorm.doc

Microsoft Word - Prior Authorization Request Form for Zelnorm.doc

Add to Reading List

Source URL: www.mainecarepdl.org

Language: English - Date: 2012-04-02 14:37:36
7Major Drug Manufacturer Novartis to Pay $422.5 Million to Settle Claims of Off-Label Drug Marketing and Kickbacks

Major Drug Manufacturer Novartis to Pay $422.5 Million to Settle Claims of Off-Label Drug Marketing and Kickbacks

Add to Reading List

Source URL: www.tn.gov

Language: English - Date: 2011-07-20 17:30:31
8Microsoft Word - Summary Minutes-GIDAC 17Nov2011 _signed_.doc

Microsoft Word - Summary Minutes-GIDAC 17Nov2011 _signed_.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
9NDA[removed]Page 3 Zelnorm™ (tegaserod maleate) Tablets

NDA[removed]Page 3 Zelnorm™ (tegaserod maleate) Tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 15:48:26
10Transcript of FDA Press Conference on the Discontinued Marketing of Zelnorm  FTS HHS FDA Moderator: Susan Cruzan March 30, [removed]:30 am CT

Transcript of FDA Press Conference on the Discontinued Marketing of Zelnorm FTS HHS FDA Moderator: Susan Cruzan March 30, [removed]:30 am CT

Add to Reading List

Source URL: www.fda.gov

Language: English